SCHEMBL3625864

SCHEMBL3625864

O=C1Oc2ccccc2CN1c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.44
MAOB P27338 4/20 0.44
NAAA Q02083 1/20 0.44
RAB9A P51151 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
GRM2 Q14416 1/20 0.43
FAAH O00519 1/20 0.43
NPC1 O15118 2/20 0.43
PKM P14618 1/20 0.43
MMP13 P45452 1/20 0.42
GSTP1 P09211 1/20 0.42
ADAMTS4 O75173 1/20 0.41
ADAMTS5 Q9UNA0 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552703 0.88 SNRNP200 (0.52) MAOAMAOBNAAAL3MBTL1
SCHEMBL2784147 0.81 NPC1 (0.51) MAOAMAOBRAB9ASMN1; SMN2GAA
SCHEMBL2767357 0.80 NPC1 (0.59) MAOBRAB9AL3MBTL1MAPTGRM2
SCHEMBL3625862 0.80 SNRNP200 (0.50) MAOAMAOBL3MBTL1MAPTSLC6A2
SCHEMBL3550361 0.79 HIF1A (0.46) NAAARAB9ASMN1; SMN2MAPTNPC1
SCHEMBL2767899 0.78 TSHR (0.45) MAOAMAOBRAB9ASMN1; SMN2GAA
SCHEMBL24398595 0.74 TSHR (0.54) RAB9AL3MBTL1MAPTNPC1LMNA
SCHEMBL9484103 0.72 GRM2 (0.60) MAOAMAOBGRM2
SCHEMBL9484108 0.72 GRM2 (0.60) MAOAMAOBGRM2
SCHEMBL5697582 0.72 MMP13 (0.54) MAOAMAOBRAB9AL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795251-B2 3,4-dihydro-benzo[e][1,3]oxazin-2-ones NOVARTIS AG (CH) 2010-09-14 US disclosed
EP-1874742-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES Novartis AG (CH) 2008-01-09 EP disclosed
WO-2006108671-A1 3,4-DIHYDRO-BENZO[E][1,3]OXAZIN-2-ONES NOVARTIS AG (CH) 2006-10-19 WO disclosed